Ultima_hora

COMUNICADO: COVID-19: La FDA aprueba el uso del test LumiraDx en el punto de atención (2)

Logo -- https://mma.prnewswire.com/media/1231165/LumiraDx_Logo.jpg [https://c212.net/c/link/?t=0&l=es&o=2891881-1&h=3826542118&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2891881-1%26h%3D4201890240%26u%3Dhttps%253A%252F%252Fmma.prnewswire.com%252Fmedia%252F1231165%252FLumiraDx_Logo.jpg%26a%3Dhttps%253A%252F%252Fmma.prnewswire.com%252Fmedia%252F1231165%252FLumiraDx_Logo.jpg&a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1231165%2FLumiraDx_Logo.jpg]

CONTACTO: CONTACTO: Cassandra Hoch, Media@LumiraDx.com

Sitio Web: https://www.lumiradx.com//

Comentarios
Somos ECD
Periodismo libre, valiente, independiente, indispensable